Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to study the effects of preoperative antithrombin
supplementation in patients undergoing cardiac surgery with cardiopulmonary bypass in order
to maintain antithrombin levels in a range greater than 58% of functional activity and,
eventually, to decrease negative clinical outcomes during the ICU stay.